title: Response to letter of Vahle et al.
authors.forename: Jacquelin
authors.initials: J
authors.lastname: Jolette
authors.forename: Clynn E
authors.initials: CE
authors.lastname: Wilker
authors.forename: John
authors.initials: J
authors.lastname: Fox
mesh_terms: D000818:Animals; D015197:Carcinogenicity Tests / Q000379:methods*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D009374:Neoplasms, Experimental / Q000139:chemically induced* / Q000453:epidemiology; D010281:Parathyroid Hormone / Q000493:pharmacokinetics / Q000633:toxicity*; D051381:Rats; D011916:Rats, Inbred F344; D011994:Recombinant Proteins / Q000493:pharmacokinetics / Q000633:toxicity; D018570:Risk Assessment; D019379:Teriparatide / Q000633:toxicity
chemical_list: D010281:Parathyroid Hormone; D011994:Recombinant Proteins; D019379:Teriparatide